Congrats to @EinsteinPhD student Eric Liu, and his mentor @hilda_ye, on receiving a Best Poster Award at the 21st Biennial International Conference on Human Retrovirology: HTLV and related viruses! Read more here: https://t.co/ULpgcwm2Ch
The recent department of cell biology annual retreat brought together faculty, students, postdocs, and staff for a lively exchange of scientific ideas and opportunities for socializing and team building. https://t.co/eOzjKGpxqm @EinsteinCellBio@MontefioreNYC@SteidlUli#SciComm
Very Happy to collaborate with my colleague Alex Sica on this piece for OncLive.
Location Matters: US Patients With Adult T-Cell Leukemia/Lymphoma Have Distinct Clinical, Genetic Features https://t.co/RiIVpb9JtP via @onclive
The @EinsteinCellBio department is excited for the 2023-2024 academic year! Please check out our updated website (https://t.co/kcNYWbsSa0) and follow us on social media to learn more about our science, training environment, and upcoming events!
@EinsteinMed@theNCI@MontefioreNYC I wish this official tweet had room for a figure legend. This picture shows the famous ATLL flower cells. Source: https://t.co/bk7Q8Q6sV3
I am recruiting two postdoc fellows for a 5-yr NIH funded project on adult T-cell leukemia/lymphoma. A unique cancer model where HTLV-1 meets epigenetics meets CD4 T cells. Great translational potential. A vibrant and expanding department. https://t.co/GR3iZC81lT
Our Latest @vkprasadlab
Clinical trials enroll X pts per month
Which factors speed & slow enrollment?
Crossover & 2:1 randomization r touted as enticements-- but do nothing!
How common or rare a tumor is... Nothing!
How active the drug is? Nope
Instead Company matters! 👇
🧵
This makes me so mad. We acknowledged a NCI Moonshot grant in one of our publications. This funding mechanism requires immediate open access publishing. The cost of open access for this @CellCellPress paper: $9,900.
@morinryan I see. Your view is certainly supported by your extensive analysis. It’s a pity such hugely divergent mutation profiles from different groups didn’t sound loud enough of an alarm for experts to dig deep sooner
@morinryan The multi-omics era posts special challenges to journal reviewers. Perhaps journals should have a panel of “platform experts”, and assign one of them to help review these papers, just as a statistician is always required to review trial protocols
PhDs can be challenging and public discourse tends to focus on the negatives.
To bring back some balance and positive momentum, this group of students sought to highlight the positive elements of the PhD experience. #AcademicChatter#PhDChat https://t.co/JatTc7cnIe
We lost our founder and friend Dr. Paul Frenette far too soon. A new review (@stemcellreports@ISSCR) from Dr. Ito @Einstein_SCI@EinsteinMed and colleagues reviews 2 research topics #StemCell#SickleCell that formed the basis of Paul’s outstanding career. https://t.co/h6ogGwOQgd
Our #ASH Friday Scientific Workshop on Germline Predisposition to Bone Marrow Failure and Hematopoietic Malignancies has been approved. We meet for the 7th time on a Friday preceding the American Society of #hematology annual meeting to discuss exciting new research findings.